The stock price

Quote
anonymous said:
I don’t know rare disease but I have a view in other specialty divisions. All examples of Pfizer idiocy and arrogance.
Hire people with relevant disease state, product or market expertise. Discount most of what they say. Replace them with Pfizer primary care leaders until they fail or get promoted or both. Then rinse and repeat

The big institutional investors try to make sense out of our behaviors and can’t. They put $$ elsewhere
Click to expand...
You are 100% correct. Don't forget one point: the Pfizer primary care "leaders" coming in as replacements are the cronies of someone higher up the chain. Many times, at least in my experience, they have little relevant disease state or market expertise.
 






anonymous said:
Buckle up - major cut’s coming in the Fall. Albert’s spending spree is over and so is he
Click to expand...

I wonder if Zoetis is willing to trade our veterinarian for their business leader. Board made the wrong choice when they let KP escape to run Zoetis. PFE got stuck with leaders unable to capitalize on a revenue and profit bonanza and far too mired in self congratulatory media tours. I would take Kristin back anytime
 






Saw that we are getting a new Investor Relations person. She’s got some work to do.

Advice from the gallery is don’t repeat whatever we’ve been doing. It’s not effective.
 






I saw that AB was recognized as the most social media active CEO in pharma. I expect our stock to skyrocket when investors see that we lead the industry in such vital measures.
 






That Cantor Fitzgerald interview was an absolute joke. I felt like the woman interviewing him was interviewing Joe Biden. What’s your favorite flavor ice cream? Did you speak with your grandkids today? I joke but her questions were designed to make AB look good. Every investor wants to know what the heck is happening with the stock price. AB, the stock price is down over 40% YTD, what is your message to the investment community and what is your plan to turn it around? The stock has struggled vs. its peer group, what is your message to investors? It will be difficult to justify any bonus this year for the ELT. We would be on a plan if we delivered these pathetic results.
 






anonymous said:
That Cantor Fitzgerald interview was an absolute joke. I felt like the woman interviewing him was interviewing Joe Biden. What’s your favorite flavor ice cream? Did you speak with your grandkids today? I joke but her questions were designed to make AB look good. Every investor wants to know what the heck is happening with the stock price. AB, the stock price is down over 40% YTD, what is your message to the investment community and what is your plan to turn it around? The stock has struggled vs. its peer group, what is your message to investors? It will be difficult to justify any bonus this year for the ELT. We would be on a plan if we delivered these pathetic results.
Click to expand...

This, exactly this! It is incredible that our executives are not held to the highest possible standard for performance. Ethical performance and behaviors are expected, but this dismal performance in the market is unacceptable. No cogent message to investors, no real plan following the Covid products bonanza. How the ELT can turn a bonanza into a boondoggle and keep their extravagant pay is beyond belief.
 






anonymous said:
I saw that AB was recognized as the most social media active CEO in pharma. I expect our stock to skyrocket when investors see that we lead the industry in such vital measures.
Click to expand...

It was top “performing CEO” and this is where we get accolades?

according to Fierce Pharma about digital content “Healthcare professionals don’t trust your digital content. That is the stark conclusion of a survey of HCPs, which found 80% of consultants are skeptical of pharma content because of doubts about the cherry-picking of data and other concerns.”

I get that digital content and social media are different things, but still….


Graphite Digital uncovered the lack of trust by talking to consultant-level HCPs specializing in oncology and urology in the U.S., the U.K. and France. The conversations revealed suspicions about the objectivity of the data provided by pharma companies. HCPs accepted pharma companies won’t publish information that is completely inaccurate, but many believe their content requires interpretation and scrutiny.
 












anonymous said:
hey come on, give them a break here...many of them have been busy writing books about themselves that no one wants to read, then pushing each others books on social media
Click to expand...
Nothing much has changed in 25 years. If we didnt buy Oncology and COX-2 Franchise from Upjohn/Pharmacia 20 years ago, and Lipitor from Parke Davis 25 years ago, I'm guessing that we would be the size of a UCB or Lundbeck. And our HQ would be in Overland Park, KS instead of NYC.
 






anonymous said:
Nothing much has changed in 25 years. If we didnt buy Oncology and COX-2 Franchise from Upjohn/Pharmacia 20 years ago, and Lipitor from Parke Davis 25 years ago, I'm guessing that we would be the size of a UCB or Lundbeck. And our HQ would be in Overland Park, KS instead of NYC.
Click to expand...
What an idiotic statement.
 












anonymous said:
Nothing much has changed in 25 years. If we didnt buy Oncology and COX-2 Franchise from Upjohn/Pharmacia 20 years ago, and Lipitor from Parke Davis 25 years ago, I'm guessing that we would be the size of a UCB or Lundbeck. And our HQ would be in Overland Park, KS instead of NYC.
Click to expand...
What about Wyeth’s vaccine division? Think that brought in some money?
 






anonymous said:
What about Wyeth’s vaccine division? Think that brought in some money?
Click to expand...
Unfortunately, with that division's vaccines came their senior-level people that wouldn't been higher on the org chart than director in marketing, and district business manager in sales if they were here in 2004-2009. Awful. Absolutely awful.
 












anonymous said:
Unfortunately, with that division's vaccines came their senior-level people that wouldn't been higher on the org chart than director in marketing, and district business manager in sales if they were here in 2004-2009. Awful. Absolutely awful.
Click to expand...

Which is what happens when you have a sole source vaccine ( Prevnar) mandating its use by the AAP that brings in billions of dollars. Reps getting their nails done, going to the gym and management/marketing going along for the ride. It was a nice ride for them while it lasted. It did bring in lots of $$ though.
 






anonymous said:
Unfortunately, with that division's vaccines came their senior-level people that wouldn't been higher on the org chart than director in marketing, and district business manager in sales if they were here in 2004-2009. Awful. Absolutely awful.
Click to expand...

I didn’t find that to be true. I thought most that I met were genuine and made me happy that I transferred over for Prevnar adult. It went downhill when when the Pfizer people started getting the top jobs. No fun anymore and doesn’t feel like a great division now.
One exception from Wyeth was Shutta. I met him at a sales meeting. What a blowhard.
 






anonymous said:
I didn’t find that to be true. I thought most that I met were genuine and made me happy that I transferred over for Prevnar adult. It went downhill when when the Pfizer people started getting the top jobs. No fun anymore and doesn’t feel like a great division now.
One exception from Wyeth was Shutta. I met him at a sales meeting. What a blowhard.
Click to expand...
 






anonymous said:
I didn’t find that to be true. I thought most that I met were genuine and made me happy that I transferred over for Prevnar adult. It went downhill when when the Pfizer people started getting the top jobs. No fun anymore and doesn’t feel like a great division now.
One exception from Wyeth was Shutta. I met him at a sales meeting. What a blowhard.
Click to expand...
In my experience legacy Pfizer people that get top jobs after an acquisition are the ones that are inept. It was that way when I first came here from PD, too.
 






Stock down 25% YTD. LOL need to get another pandemic to save PFE
Albert,........focus on the stock price and not going woke! No excuses,
no one wants your vaccine boosters, they don't work! (spare me the
"it stops you from being hospitalized" rhetoric) - show me comparative
studies in otherwise healthy people that got covid and were hospitalized,
(Elderly/High Risk their choice) that you have to show with any other NDA
Based on his performance he should be Pfired!!
 






anonymous said:
Stock down 25% YTD. LOL need to get another pandemic to save PFE
Albert,........focus on the stock price and not going woke! No excuses,
no one wants your vaccine boosters, they don't work! (spare me the
"it stops you from being hospitalized" rhetoric) - show me comparative
studies in otherwise healthy people that got covid and were hospitalized,
(Elderly/High Risk their choice) that you have to show with any other NDA
Based on his performance he should be Pfired!!
Click to expand...

The board should be cleaning house of the entire leadership team based on the dismal forecast for continued Covid vaccine sales. This is entirely due to the awful stewardship of public understanding and trust. Secondly, they should be marched out due to the horrid use of early Covid revenues. Free money flowing in and the ELT was following the siren song of media and politics. Fools, all of them. Especially AB, Koalemos.
 






Top Bottom
Back
Quote